Pfizer and BioNTech expect to seek emergency use authorization for their COVID-19 booster vaccine in all adults 18 years and older; the Biden administration urges appeals court to not block employer vaccine mandate; nearly 8 in 10 Americans believe or are unsure of false COVID-19 information.
As reported by The Washington Post, Pfizer/BioNTech are expected to seek emergency use authorization for their COVID-19 booster vaccine in all adults 18 years and older. The request, which could be filed as soon as this week, will likely be approved by the FDA and comes amid concerns from some health experts that infections and deaths from the declining Delta surge might be plateauing at a high level. Currently, the Pfizer booster shots are available for individuals 65 years and older or those aged 18 to 64 who are at high risk of severe COVID-19 or work in areas that increase risk.
The Biden administration issued a 28-page filing yesterday to the United States Court of Appeals for the Fifth Circuit arguing that the federal government had all the necessary power to require large employers to mandate COVID-19 vaccination or weekly testing and mask wearing in their workforce. Following the court’s temporary halting of the mandate last week, The New York Times reports the Department of Justice contended that the rule was necessary to protect workers from the pandemic and had legal standing. If passed, the rule would force companies with at least 100 employees to require unvaccinated employees to wear masks starting December 5 and adhere to weekly testing at work starting January 4.
A poll published yesterday by Kaiser Family Foundation indicated that 78% of US adults believe or are unsure of at least 1 of 8 false statements regarding COVID-19. As reported by The Hill, trends in misinformation included 38% who believe the government is exaggerating COVID-19 deaths, 17% who believe pregnant women should not get the vaccine, and 18% who believe vaccine-related deaths are being hidden by the government. Notably, unvaccinated individuals were found to be much more likely to believe or be unsure of 4 or more of the false statements compared with vaccinated people (64% vs 19%).
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Data analysis showed that 40% of patients who filled a prescription for Wegovy in 2021 or 2022 were still taking it a year later; both Democrats and reproductive rights organizations are pressuring the Biden administration to ensure health insurers fully cover contraception; CMS implemented Medicare changes in March that limited access to blood tests that help transplant recipients ensure their organs remain healthy.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Dr Kathryn Lindley Explains the Importance of Cardio-Obstetrics in Fellowship Programs
December 5th 2023Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, talks about why it’s important to incorporate cardio-obstetrics training into cardiovascular disease fellowship programs.
Read More